Merck Wins PTAB Review Of Pfizer Pneumonia Vax Patent
The Patent Trial and Appeal Board agreed Tuesday to review a patent related to Pfizer Inc.'s top-selling Prevnar 13 pneumonia vaccine, finding Merck Sharp & Dohme Corp. showed the patent was...To view the full article, register now.
Already a subscriber? Click here to view full article